| scholarly article | Q13442814 |
| P50 | author | Christopher T Sica | Q80052285 |
| P2093 | author name string | Amanda M Snyder | |
| James R Connor | |||
| Jennifer Baccon | |||
| Xuemei Huang | |||
| Richard B Mailman | |||
| Guangwei Du | |||
| Lan Kong | |||
| Mechelle M Lewis | |||
| Christy Stetter | |||
| Felicia Cooper | |||
| Ben Murie | |||
| P2860 | cites work | Magnetic resonance imaging as a potential biomarker for Parkinson's disease. | Q38695637 |
| α-Synuclein and Parkinsonism: Updates and Future Perspectives | Q38742153 | ||
| The Key Determinants to Quality of Life in Parkinson's Disease Patients: Results from the Parkinson's Disease Biomarker Program (PDBP). | Q38852910 | ||
| Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care | Q39179797 | ||
| Magnetic resonance imaging for the diagnosis of Parkinson's disease | Q39220904 | ||
| Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease. | Q40202363 | ||
| Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts. | Q43526336 | ||
| Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. | Q43899144 | ||
| Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy | Q44649068 | ||
| Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy | Q44649355 | ||
| Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping | Q47925584 | ||
| 100 years of Lewy pathology | Q48278741 | ||
| Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. | Q48307154 | ||
| Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. | Q48327092 | ||
| Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias | Q48383261 | ||
| Copper, iron and zinc in Alzheimer's disease senile plaques | Q48429285 | ||
| Differentiation of typical and atypical Parkinson syndromes by quantitative MR imaging. | Q48841126 | ||
| Involvement of the cerebellum in Parkinson disease and dementia with Lewy bodies | Q50240143 | ||
| Susceptibility phase imaging with comparison to R2 mapping of iron-rich deep grey matter. | Q50539264 | ||
| Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. | Q50562845 | ||
| Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. | Q52926826 | ||
| Quantitative MR imaging of brain iron: a postmortem validation study | Q56778727 | ||
| Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains | Q61714001 | ||
| Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain | Q61714016 | ||
| Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients | Q64871603 | ||
| Cell counts in the substantia nigra: a comparison of single section counts and disector counts in patients with Parkinson's disease and in controls | Q72286058 | ||
| Midbrain iron content in early Parkinson disease: a potential biomarker of disease status | Q80437646 | ||
| High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease | Q22065275 | ||
| Ageing and Parkinson's disease: substantia nigra regional selectivity | Q29615835 | ||
| User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability | Q29615939 | ||
| DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease | Q30493811 | ||
| Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus | Q30577479 | ||
| Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker | Q30837513 | ||
| Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging. | Q30846734 | ||
| Imaging iron stores in the brain using magnetic resonance imaging | Q30983609 | ||
| Role of iron in neurodegenerative diseases | Q31038817 | ||
| Anatomy of the substantia nigra and subthalamic nucleus on MR imaging | Q33517187 | ||
| Effects of aging on the ventral and dorsal substantia nigra using diffusion tensor imaging | Q34014486 | ||
| Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study | Q34043770 | ||
| Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease | Q34336792 | ||
| Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort. | Q34383377 | ||
| A double-blind, delayed-start trial of rasagiline in Parkinson's disease | Q34612128 | ||
| National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease | Q34635272 | ||
| Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson's disease | Q35159185 | ||
| Contributions to magnetic susceptibility of brain tissue | Q36033901 | ||
| Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy | Q36142223 | ||
| Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study | Q36147421 | ||
| Case control study of diffusion tensor imaging in Parkinson's disease. | Q36172532 | ||
| Imaging nigral pathology and clinical progression in Parkinson's disease | Q36434577 | ||
| Age and sex related differences in subcortical brain iron concentrations among healthy adults | Q36533947 | ||
| Iron accumulation in Alzheimer disease is a source of redox-generated free radicals | Q36577461 | ||
| Accuracy of the morphology enabled dipole inversion (MEDI) algorithm for quantitative susceptibility mapping in MRI. | Q36732418 | ||
| Progressive supranuclear palsy: pathology and genetics | Q36817215 | ||
| Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis | Q36956592 | ||
| Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor | Q37106984 | ||
| Multi-atlas segmentation of subcortical brain structures via the AutoSeg software pipeline | Q37558908 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1432-1439 | |
| P577 | publication date | 2018-05-14 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes | |
| P478 | volume | 33 |
| Q59544049 | An update on advances in magnetic resonance imaging of multiple system atrophy |
| Q64252277 | Brain Iron Accumulation in Atypical Parkinsonian Syndromes: MRI Evidences for Distinctive Patterns |
| Q64871603 | Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients |
| Q58574554 | Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson's disease |
| Q64780339 | Multimodal MRI evaluation of parkinsonian limbic pathologies |
| Q64759313 | Structural Imaging in Parkinson's Disease: New Developments |
| Q64763413 | Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease |
Search more.